ராஜீவ் திவான் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ராஜீவ் திவான். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ராஜீவ் திவான் Today - Breaking & Trending Today

Board of Trident approves change in directorate


At meeting held on 15 May 2021The Board of Trident at its meeting held on 15 May 2021 has approved the change in designation of Rajiv Dewan as Chairman of the Board of Directors with immediate effect. The Board has accepted the resignation of Pallavi Shroff as Director of the company with immediate effect. The Board also appointed Usha Sangwan as Additional Director of the company with immediate effect.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid ....

Rajiv Dewan , Pallavi Shroff , Usha Sangwan , Additional Director , Capital Market , ராஜீவ் திவான் , பல்லவி ஷ்ரொப்ப் , உஷா சாங்குவான் , மூலதனம் சந்தை ,

Avisa Diagnostics Inc. (Formerly, FogChain Corp.) Announces Closing of Reverse Takeover Transaction


Share:
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
SANTA FE, N. M., May 04, 2021 (GLOBE NEWSWIRE) Avisa Diagnostics Inc. (formerly, FogChain Corp.) (the Company ) is pleased to announce the closing of its previously announced reverse takeover transaction (the Transaction ) with Avisa Pharma Inc. ( Avisa ). In accordance with the merger agreement and plan of reorganization dated February 1, 2021 (the Merger Agreement ), which superseded and replaced the previously announced Letter of Intent dated January 12, 2021, the Transaction was effected by way of a triangular merger between the Company, Avisa, and a wholly owned, Delaware subsidiary of the Company ( Subco ) pursuant to the laws of the State of Delaware. The combined public company resulting from the Transaction (the Resulting Issuer ) will carry on the business of Avisa. ....

United States , United Kingdom , State Of Delaware , Prince Edward Island , Avisa Breathtest , Brian Birk , Davids Joseph , Rajeev Dewan , Fogchain Corp The Company , Avisa Pharma Inc , Company The Common , Listing Of The Company , Avisa Diagnostics Inc , Canadian Securities Exchange , Company Subco , Fogchain Corp , Avisa Pharma , British Columbia , New Brunswick , Nova Scotia , Common Shares , Chief Executive Officer , Matthew Culler , Vice President , Chief Financial Officer , Corporate Secretary ,

চাঁদপুরে ছাত্রলীগের জনসচেতনতামূলক ক্যাম্পেইন ও মাস্ক বিতরণ